MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202611069668 A) filed by Sunil Kumar Tiwari; Ms. Neha Nanasaheb Khebude; Ms. Snehal Sanjay Jadhav; Krutika Arun More; Dr. Dilip Kumar Tiwari; Srividhya V; Pranita Kokare; Sheetal Sen; Rati Raj; Mr. Vinod Matole; Averineni Ravi Kumar; and Yash Srivastav on June 03, 2026, for Development Of Artificial Intelligence-Assisted 3d-Printed Biodegradable Hydrogel Microneedle System For Controlled Transdermal Delivery Of Trimethoprim-Loaded Solid Lipid Nanoparticles..
Inventors include Sunil Kumar Tiwari; Ms. Neha Nanasaheb Khebude; Ms. Snehal Sanjay Jadhav; Krutika Arun More; Dr. Dilip Kumar Tiwari; Srividhya V; Pranita Kokare; Sheetal Sen; Rati Raj; Mr. Vinod Matole; Averineni Ravi Kumar; and Yash Srivastav.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: Abstract The present invention relates to an artificial intelligence-assisted transdermal drug delivery platform comprising 3D-printed biodegradable hydrogel microneedles loaded with trimethoprim-containing solid lipid nanoparticles. Machine learning algorithms optimize microneedle geometry, hydrogel composition, nanoparticle characteristics, and drug release profiles based on patient-specific parameters. The microneedles are fabricated using high-resolution additive manufacturing techniques and penetrate the skin painlessly to deliver therapeutic agents in a controlled manner. The biodegradable hydrogel matrix gradually dissolves, releasing trimethoprim-loaded nanoparticles for sustained antimicrobial action. The invention provides improved bioavailability, enhanced patient compliance, personalized therapy, reduced systemic side effects, and scalable manufacturing capabilities for next-generation transdermal antibiotic delivery systems.
Disclaimer: Curated by HT Syndication.
